May 19, 2011 - Barco has launched the Mammo Tomosynthesis 5 MP, the first display system that has been cleared by the U.S. Food and Drug Administration (FDA) for breast tomosynthesis. The display comes with some groundbreaking technologies specifically developed for multi-modality mammography.

The Mammo Tomosynthesis 5MP efficiently displays high-quality multi-modality images. Barco's RapidFrame technology speeds pixel refresh when reviewing multi-frame image sequences such as tomosynthesis or breast MRI, eliminating blurring or ghosting. Combined with Barco's Per Pixel Uniformity (PPU) to remove disturbing screen noise, the display renders mammograms with the best image quality, helping radiologists make accurate diagnoses while speeding up their workflow.

Equipped with the powerful DuraLight Nova backlight, the Mammo Tomosynthesis display offers twice the calibrated brightness (1,000 cd/m²) of conventional displays, while more than doubling the lamp lifetime (50,000 hours). This luminance enables radiologists to see fine details in dense breast tissue and renders near skin-line details more clearly. The display also provides an I-Luminate “hot light” button for extra brightness, which can reveal subtle details, even in dark areas.

The Mammo Tomosynthesis 5MP comes with an adjustable dual-head stand and allows users to angle the displays to their preferred position for optimum viewing. Additionally, the display can be viewed from a wide angle, without sacrificing contrast or black level. Images can now be read from any seat at the reading station, allowing radiologists to discuss the images with colleagues in the room or use them for educational purposes.

The display system's intrinsic brightness reduces eye fatigue and enables reading in a more pleasant ambient room light, preserving visibility of low-contrast details. It also includes the integrated I-Guard sensor, extra-large knee Array coil for the Vantage Titan MR system, which automatically checks contrast and luminance. This provides radiologists with an optimal work environment, boosting diagnostic performance and productivity.

For more information: www.barco.com


Related Content

News | Breast Imaging

April 2, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced ...

Time April 02, 2024
arrow
News | Breast Imaging

March 20, 2024 — Interval breast cancer is one that appears between two reviews of a screening program. That is, it is ...

Time March 20, 2024
arrow
News | Breast Imaging

March 15, 2024 — Screening-detected radial scars without atypia at core-needle biopsy (CNB) have a low upstaging rate to ...

Time March 15, 2024
arrow
News | Information Technology

March 12, 2024 — Demonstrating how advanced display solutions improve staff and patient experiences throughout modern ...

Time March 12, 2024
arrow
News | Breast Imaging

March 6, 2024 — There is a pressing need to explore and understand which social determinants of health (SDOH) and health ...

Time March 06, 2024
arrow
News | Breast Imaging

February 20, 2024 — Annual breast cancer screening beginning at age 40 and continuing to at least age 79 results in the ...

Time February 20, 2024
arrow
News | Breast Imaging

February 9, 2024 — An innovative breast imaging technique provides high sensitivity for detecting cancer while ...

Time February 09, 2024
arrow
News | Breast Density

December 22, 2023 — Volpara Health Technologies Ltd., a global leader in software for the early detection and prevention ...

Time December 22, 2023
arrow
News | Breast Imaging

December 11, 2023 — A new deep learning challenge has been launched by the UEF Cancer AI research team, led by senior ...

Time December 11, 2023
arrow
News | RSNA

November 30, 2023 — Breast cancer mortality is significantly reduced when women regularly attend screening mammograms ...

Time November 30, 2023
arrow
Subscribe Now